Fundamentals of fractional laser-assisted drug delivery: An in-depth guide to experimental methodology and data interpretation.

In the decade since their advent, ablative fractional lasers have emerged as powerful tools to enhance drug delivery to and through the skin. Effective and highly customizable, laser-assisted drug delivery (LADD) has led to improved therapeutic outcomes for several medical indications. However, for LADD to reach maturity as a standard treatment technique, a greater appreciation of its underlying science is needed. This work aims to provide an in-depth guide to the technology's fundamental principles, experimental methodology and unique aspects of LADD data interpretation. We show that drug's physicochemical properties including solubility, molecular weight and tissue binding behavior, are crucial determinants of how laser channel morphology influences topical delivery. Furthermore, we identify strengths and limitations of experimental models and drug detection techniques, interrogating the usefulness of in vitro data in predicting LADD in vivo. By compiling insights from over 75 studies, we ultimately devise an approach for intelligent application of LADD, supporting its implementation in the clinical setting.

[1]  B. Blough,et al.  Effects of chemical and physical enhancement techniques on transdermal delivery of 3-fluoroamphetamine hydrochloride. , 2017, International journal of pharmaceutics.

[2]  S. Hackbarth,et al.  Investigation of Polylactic Acid (PLA) Nanoparticles as Drug Delivery Systems for Local Dermatotherapy , 2009, Pharmaceutical Research.

[3]  J. Brandner,et al.  Tight junctions in skin inflammation , 2016, Pflügers Archiv - European Journal of Physiology.

[4]  U. Paasch,et al.  Case reports on the potential of fractional laser-assisted photodynamic therapy for basal cell carcinomas , 2012, Lasers in Medical Science.

[5]  Hung-Hsu Yang,et al.  Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[6]  P. Philipsen,et al.  Comparison of Physical Pretreatment Regimens to Enhance Protoporphyrin IX Uptake in Photodynamic Therapy: A Randomized Clinical Trial , 2017, JAMA dermatology.

[7]  J Bajgar,et al.  Transdermal drug delivery in vitro using diffusion cells. , 2012, Current medicinal chemistry.

[8]  Hung-Hsu Yang,et al.  Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[9]  J. Bos,et al.  The 500 Dalton rule for the skin penetration of chemical compounds and drugs , 2000, Experimental dermatology.

[10]  W. R. Lieb,et al.  Biological Membranes behave as Non-porous Polymeric Sheets with Respect to the Diffusion of Non-electrolytes , 1969, Nature.

[11]  A. Doukas,et al.  Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment , 2011, Lasers in surgery and medicine.

[12]  S L Jacques,et al.  Controlled removal of human stratum corneum by pulsed laser. , 1987, The Journal of investigative dermatology.

[13]  J. Walsh,et al.  Er:YAG laser ablation of tissue: Measurement of ablation rates , 1989, Lasers in surgery and medicine.

[14]  R. Anderson,et al.  Fractional CO2 laser‐assisted drug delivery , 2010, Lasers in surgery and medicine.

[15]  Y. Kalia,et al.  Needle-free cutaneous delivery of living human cells by Er:YAG fractional laser ablation , 2018, Expert opinion on drug delivery.

[16]  M. Vlk,et al.  Fractional Carbon Dioxide Laser Improves Nodular Basal Cell Carcinoma Treatment with Photodynamic Therapy with Methyl 5‐Aminolevulinate , 2013, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[17]  C. Janfelt,et al.  Fractional laser‐assisted drug delivery: Laser channel depth influences biodistribution and skin deposition of methotrexate , 2016, Lasers in surgery and medicine.

[18]  M. Haedersdal,et al.  Ablative fractional laser enhances MAL-induced PpIX accumulation: Impact of laser channel density, incubation time and drug concentration. , 2016, Journal of photochemistry and photobiology. B, Biology.

[19]  D. Miklavčič,et al.  The effect of pulse duration, power and energy of fractional Er:YAG laser for transdermal delivery of differently sized FITC dextrans. , 2017, International journal of pharmaceutics.

[20]  S. Arias-Santiago,et al.  Study of shrinkage of cutaneous surgical specimens , 2015, Journal of cutaneous pathology.

[21]  H. Wulf,et al.  Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial , 2012, The British journal of dermatology.

[22]  A. Banga,et al.  Transdermal delivery of human growth hormone via laser-generated micropores , 2018, Drug Delivery and Translational Research.

[23]  G. Winter,et al.  Application of water‐soluble polyvinyl alcohol‐based film patches on laser microporated skin facilitates intradermal macromolecule and nanoparticle delivery , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[24]  T. Olsen,et al.  Shrinkage of cutaneous specimens: formalin or other factors involved? , 2008, Journal of cutaneous pathology.

[25]  M. Mogensen,et al.  Vehicle type affects filling of fractional laser-ablated channels imaged by optical coherence tomography , 2017, Lasers in Medical Science.

[26]  Valery V. Tuchin,et al.  Transcutaneous delivery of micro- and nanoparticles with laser microporation , 2013, Journal of biomedical optics.

[27]  S. Frokjaer,et al.  Evaluation of Göttingen minipig skin for transdermal in vitro permeation studies. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  P. Elias,et al.  Morphologic basis for a pore-pathway in mammalian stratum corneum. , 1997, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[29]  Hung-Hsu Yang,et al.  Skin Permeation of Small-Molecule Drugs, Macromolecules, and Nanoparticles Mediated by a Fractional Carbon Dioxide Laser: The Role of Hair Follicles , 2012, Pharmaceutical Research.

[30]  T. Andresen,et al.  Topical delivery of vismodegib using ablative fractional laser and micro‐emulsion formulation in vitro , 2018, Lasers in surgery and medicine.

[31]  M. Shin,et al.  Comparative analysis of the effects of CO2 fractional laser and sonophoresis on human skin penetration with 5-aminolevulinic acid , 2017, Lasers in Medical Science.

[32]  R. Anderson,et al.  The impact of treatment density and molecular weight for fractional laser-assisted drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[33]  T. Maisch,et al.  Penetration enhancement of two topical 5‐aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation , 2010, Experimental dermatology.

[34]  Y. Kalia,et al.  Transcutaneous vaccination via laser microporation , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[35]  S. Shen,et al.  Is the Fractional Laser Still Effective in Assisting Cutaneous Macromolecule Delivery in Barrier-Deficient Skin? Psoriasis and Atopic Dermatitis as the Disease Models , 2018, Pharmaceutical Research.

[36]  Y. Hiruta,et al.  Transcutaneous drug delivery by liposomes using fractional laser technology , 2017, Lasers in surgery and medicine.

[37]  D. Selzer,et al.  Finite and infinite dosing: difficulties in measurements, evaluations and predictions. , 2013, Advanced drug delivery reviews.

[38]  Yousuf H. Mohammed,et al.  Skin models for the testing of transdermal drugs , 2016, Clinical pharmacology : advances and applications.

[39]  Mei X. Wu,et al.  Sustained epidermal powder drug delivery via skin microchannels☆ , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[40]  Y. Kalia,et al.  Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[41]  M. Haedersdal,et al.  Opportunities for laser-assisted drug delivery in the treatment of cutaneous disorders. , 2017, Seminars in cutaneous medicine and surgery.

[42]  C. Berking,et al.  Laser‐assisted photodynamic therapy for actinic keratosis: A systematic review and meta‐analysis , 2019, Journal of the American Academy of Dermatology.

[43]  R. Scheuplein,et al.  Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. , 1967, The Journal of investigative dermatology.

[44]  J. Hannibal,et al.  Laser‐induced thermal coagulation enhances skin uptake of topically applied compounds , 2017, Lasers in surgery and medicine.

[45]  S. Shen,et al.  Noninvasive delivery of siRNA and plasmid DNA into skin by fractional ablation: erbium:YAG laser versus CO₂ laser. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[46]  José Juan Escobar-Chávez,et al.  The tape-stripping technique as a method for drug quantification in skin. , 2008, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[47]  H. Benson,et al.  Transdermal drug delivery: penetration enhancement techniques. , 2005, Current drug delivery.

[48]  Y. Kalia,et al.  Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[49]  K. Arndt,et al.  The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. , 2008, Journal of the American Academy of Dermatology.

[50]  P. Caravan,et al.  Laser‐assisted delivery of synergistic combination chemotherapy in in vivo skin , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[51]  R. Anderson,et al.  Fractional laser‐assisted delivery of methyl aminolevulinate: Impact of laser channel depth and incubation time , 2012, Lasers in surgery and medicine.

[52]  R. Anderson,et al.  Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: A critical review from basics to current clinical status. , 2016, Journal of the American Academy of Dermatology.

[53]  M. Roberts,et al.  Using a simple equation to predict the microporation‐enhanced transdermal drug flux , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[54]  T J Flotte,et al.  Photomechanical transdermal delivery: The effect of laser confinement , 2001, Lasers in surgery and medicine.

[55]  Valery V Tuchin,et al.  In vivo optical monitoring of transcutaneous delivery of calcium carbonate microcontainers. , 2016, Biomedical optics express.

[56]  J. Kenkel,et al.  Transdermal delivery of adipocyte-derived stem cells using a fractional ablative laser. , 2013, Aesthetic surgery journal.

[57]  A. Shabbir,et al.  Percutaneous Bone Marrow Transplantation Using Fractional Ablative Erbium:YAG Laser , 2014, PloS one.

[58]  U. Paasch,et al.  Spatiotemporal closure of fractional laser‐ablated channels imaged by optical coherence tomography and reflectance confocal microscopy , 2016, Lasers in surgery and medicine.

[59]  Ajay K. Banga,et al.  Delivery of Methotrexate and Characterization of Skin Treated by Fabricated PLGA Microneedles and Fractional Ablative Laser , 2018, Pharmaceutical Research.

[60]  M. Calderón,et al.  Drug delivery across intact and disrupted skin barrier: Identification of cell populations interacting with penetrated thermoresponsive nanogels , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[61]  H. Korting,et al.  The pH of the Skin Surface and Its Impact on the Barrier Function , 2006, Skin Pharmacology and Physiology.

[62]  T. Prow,et al.  The fractional laser‐induced coagulation zone characterized over time by laser scanning confocal microscopy—A proof of concept study , 2018, Lasers in surgery and medicine.

[63]  R. Scheuplein,et al.  Percutaneous absorption of steroids. , 1969, The Journal of investigative dermatology.

[64]  M. Haedersdal,et al.  Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side‐by‐side, single‐blind trial in patients with actinic keratosis and large‐area field cancerization , 2018, The British journal of dermatology.

[65]  T. Prow,et al.  Fractional laser‐assisted drug uptake: Impact of time‐related topical application to achieve enhanced delivery , 2017, Lasers in surgery and medicine.

[66]  S. Shen,et al.  Impact of Different Vehicles for Laser-Assisted Drug Permeation via Skin: Full-Surface versus Fractional Ablation , 2014, Pharmaceutical Research.

[67]  C. Janfelt,et al.  Fractional laser-assisted topical delivery of bleomycin quantified by LC-MS and visualized by MALDI mass spectrometry imaging , 2019, Drug delivery.

[68]  Sindy Hu,et al.  Fractional CO2 Laser Pretreatment Facilitates Transdermal Delivery of Two Vitamin C Derivatives , 2016, Molecules.

[69]  B. W. Barry,et al.  Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin. , 1988, The Journal of investigative dermatology.

[70]  R. Verdaasdonk,et al.  Drug penetration enhancement techniques in ablative fractional laser assisted cutaneous delivery of indocyanine green , 2019, Lasers in surgery and medicine.

[71]  Russell O. Potts,et al.  Predicting Skin Permeability , 1992, Pharmaceutical Research.

[72]  R. R. Anderson,et al.  Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[73]  Brian W. Barry,et al.  Mode of action of penetration enhancers in human skin , 1987 .

[74]  Jeffrey M Kenkel,et al.  Can fractional lasers enhance transdermal absorption of topical lidocaine in an in vivo animal model? , 2012, Lasers in surgery and medicine.

[75]  S. Shen,et al.  Erbium-yttrium-aluminum-garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs. , 2014, Journal of pharmaceutical sciences.

[76]  R. Scheuplein,et al.  Permeability of the Skin , 1971 .

[77]  R. Anderson,et al.  Laser-assisted delivery enhances topical uptake of the anticancer agent cisplatin , 2018, Drug delivery.

[78]  L. Schmitt,et al.  Direct biological effects of fractional ultrapulsed CO2 laser irradiation on keratinocytes and fibroblasts in human organotypic full-thickness 3D skin models , 2018, Lasers in Medical Science.

[79]  A. Wolkerstorfer,et al.  Fractional CO2 laser assisted delivery of topical anesthetics: A randomized controlled pilot study , 2016, Lasers in surgery and medicine.

[80]  S. Kežić,et al.  Parameters in fractional laser assisted delivery of topical anesthetics: Role of laser type and laser settings , 2018, Lasers in surgery and medicine.

[81]  Yvonne M. Rasko,et al.  Topical lidocaine enhanced by laser pretreatment: a safe and effective method of analgesia for facial rejuvenation. , 2013, Aesthetic surgery journal.

[82]  Sindy Hu,et al.  Transdermal delivery of three vitamin C derivatives by Er:YAG and carbon dioxide laser pretreatment , 2013, Lasers in Medical Science.

[83]  R. Anderson,et al.  Pretreatment with ablative fractional laser changes kinetics and biodistribution of topical 5‐aminolevulinic acid (ALA) and methyl aminolevulinate (MAL) , 2014, Lasers in surgery and medicine.

[84]  Véronique Préat,et al.  In Vivo Methods for the Assessment of Topical Drug Bioavailability , 2007, Pharmaceutical Research.

[85]  A. Banga Transdermal and Intradermal Delivery of Therapeutic Agents: Application of Physical Technologies , 2011 .

[86]  M. Roberts,et al.  Modelling Dermal Drug Distribution After Topical Application in Human , 2011, Pharmaceutical Research.

[87]  J. Hoopman,et al.  In vivo histopathologic comparison of the acute injury following treatment with five fractional ablative laser devices. , 2010, Aesthetic surgery journal.

[88]  Hung-Hsu Yang,et al.  Risk assessment of excess drug and sunscreen absorption via skin with ablative fractional laser resurfacing , 2013, Lasers in Medical Science.

[89]  H. Wulf,et al.  Combination of ablative fractional laser and daylight‐mediated photodynamic therapy for actinic keratosis in organ transplant recipients – a randomized controlled trial , 2015, The British journal of dermatology.

[90]  H. Maibach,et al.  In Vivo Skin Penetration of Acitretin in Volunteers Using Three Sampling Techniques , 1993, Pharmaceutical Research.

[91]  W. Ramsdell Fractional Carbon Dioxide Laser Resurfacing , 2012, Seminars in Plastic Surgery.

[92]  T. Franz Percutaneous absorption on the relevance of in vitro data. , 1975, The Journal of investigative dermatology.

[93]  Gordon Hiroshi Sasaki,et al.  Fractional CO2 laser resurfacing of photoaged facial and non-facial skin: Histologic and clinical results and side effects , 2009, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[94]  Y. Kalia,et al.  Fractional Laser Ablation for the Cutaneous Delivery of Triamcinolone Acetonide from Cryomilled Polymeric Microparticles: Creating Intraepidermal Drug Depots. , 2016, Molecular pharmaceutics.

[95]  R. Anderson,et al.  Fractional laser-assisted topical delivery leads to enhanced, accelerated and deeper cutaneous 5-fluorouracil uptake , 2017, Expert opinion on drug delivery.

[96]  H. Kanazawa,et al.  Fractional laser-assisted percutaneous drug delivery via temperature-responsive liposomes , 2017, Journal of biomaterials science. Polymer edition.

[97]  R. R. Anderson,et al.  Topically applied methotrexate is rapidly delivered into skin by fractional laser ablation , 2015, Expert opinion on drug delivery.

[98]  R. Anderson,et al.  Fractional Photothermolysis: A New Concept for Cutaneous Remodeling Using Microscopic Patterns of Thermal Injury , 2004, Lasers in surgery and medicine.

[99]  P. Philipsen,et al.  The ablative fractional coagulation zone influences skin fluorescence intensities of topically applied test molecules—An in vitro study with fluorescence microscopy and fluorescence confocal microscopy , 2018, Lasers in surgery and medicine.

[100]  R. Anderson,et al.  Ablative fractional laser alters biodistribution of ingenol mebutate in the skin , 2015, Archives of Dermatological Research.

[101]  A. Stinchcomb,et al.  Vehicle Composition Influence on the Microneedle-Enhanced Transdermal Flux of Naltrexone Hydrochloride , 2010, Pharmaceutical Research.

[102]  M. Roberts,et al.  Dermal and underlying tissue pharmacokinetics of lidocaine after topical application. , 1994, Journal of pharmaceutical sciences.

[103]  A. Doukas,et al.  Fractional laser‐assisted drug delivery: Active filling of laser channels with pressure and vacuum alteration , 2016, Lasers in surgery and medicine.

[104]  Y. Kalia,et al.  Transdermal drug delivery: overcoming the skin's barrier function. , 2000, Pharmaceutical science & technology today.

[105]  N. Kollias,et al.  Transdermal drug delivery with a pressure wave. , 2004, Advanced drug delivery reviews.

[106]  Biana Godin,et al.  Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. , 2007, Advanced drug delivery reviews.

[107]  Q. Peng,et al.  Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. , 2001, Journal of photochemistry and photobiology. B, Biology.

[108]  Hiroaki Todo,et al.  Transdermal Permeation of Drugs in Various Animal Species , 2017, Pharmaceutics.

[109]  Shih-Yi Huang,et al.  Skin pretreatment with lasers promotes the transdermal delivery of vitamin C derivatives , 2011, Lasers in Medical Science.

[110]  H. Wulf,et al.  Fractional laser‐mediated photodynamic therapy of high‐risk basal cell carcinomas – a randomized clinical trial , 2015, The British journal of dermatology.

[111]  Dieter Manstein,et al.  Micro-fractional epidermal powder delivery for improved skin vaccination. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[112]  Y. Kalia,et al.  Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966 , 2019, Scientific Reports.

[113]  Sindy Hu,et al.  Fractional Carbon Dioxide Laser Treatment to Enhance Skin Permeation of Ascorbic Acid 2‐Glucoside with Minimal Skin Disruption , 2012, Dermatologic Surgery.

[114]  Y. Kalia,et al.  Using controlled laser-microporation to increase transdermal delivery of prednisone. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[115]  U. Paasch,et al.  Lesion dimensions following ablative fractional laser treatment in non-melanoma skin cancer and premalignant lesions , 2012, Lasers in Medical Science.

[116]  M. Roberts,et al.  Blood flow measurements in skin and underlying tissues by microsphere method: application to dermal pharmacokinetics of polar nonelectrolytes. , 1993, Journal of pharmaceutical sciences.

[117]  B. Hantash,et al.  Fractional Photothermolysis: A Novel Aesthetic Laser Surgery Modality , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[118]  Y. Tu,et al.  Transdermal delivery of water‐soluble fluorescent antibody mediated by fractional Er:YAG laser for the diagnosis of lupus erythematosus in mice , 2018, Lasers in surgery and medicine.

[119]  Y. Kalia,et al.  Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[120]  Y. Kalia,et al.  Effect of controlled laser microporation on drug transport kinetics into and across the skin. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[121]  M. Roberts,et al.  Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application , 1993, Journal of Pharmacokinetics and Biopharmaceutics.

[122]  R. Anderson,et al.  Fractional ablative erbium YAG laser: Histological characterization of relationships between laser settings and micropore dimensions , 2014, Lasers in surgery and medicine.